You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Drotrecogin alfa activated

Showing 1 - 25 of 3,030
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

End Stage Renal Disease Trial in Washington (Drotrecogin alfa activated (Xigris))

Completed
Has Results
  • End Stage Renal Disease
  • Drotrecogin alfa activated (Xigris)
  • Washington, District of Columbia
    The George Washington University Hospital
Jan 6, 2022

Hemophilia A With Inhibitor, Hemophilia B With Inhibitor Trial in Teheran (Eptacog alfa, activated)

Recruiting
  • Hemophilia A With Inhibitor
  • Hemophilia B With Inhibitor
  • Eptacog alfa, activated
  • Teheran, Iran, Islamic Republic of
    Comprehensive Hemophilia Care Center
Feb 14, 2022

Hemophilia A, Hemophilia B, Hemophilia A With Inhibitor Trial in Bulgaria, Russian Federation (MarzAA (marzeptacog alfa

Completed
Has Results
  • Hemophilia A
  • +5 more
  • MarzAA (marzeptacog alfa [activated])
  • Plovdiv, Bulgaria
  • +4 more
Sep 9, 2021

Gaucher Disease, Type 1 Trial in Worldwide (VPRIV ®,)

Completed
Has Results
  • Gaucher Disease, Type 1
  • VPRIV ®,
  • Buenos Aires, Argentina
  • +4 more
Jun 28, 2021

Hemophilia A With Inhibitor, Hemophilia B With Inhibitor Trial in Worldwide (Coagulation Factor VIIa variant)

Completed
Has Results
  • Hemophilia A With Inhibitor
  • Hemophilia B With Inhibitor
  • Coagulation Factor VIIa variant
  • Yerevan, Armenia
  • +8 more
Sep 21, 2021

Factor VII Deficiency, Glanzmann Thrombasthenia, Hemophilia A With Inhibitor Trial in Worldwide (Coagulation Factor VIIa

Terminated
  • Factor VII Deficiency
  • +2 more
  • Coagulation Factor VIIa variant
  • Sacramento, California
  • +19 more
Dec 6, 2021

Gaucher Disease Trial in Hamamatsu, Minato-ku, Osaka (velaglucerase alfa)

Completed
Has Results
  • Gaucher Disease
  • velaglucerase alfa
  • Hamamatsu, Shizuoka, Japan
  • +2 more
Jun 25, 2021

Surgery Trial in Worldwide (andexanet alfa)

Terminated
  • Surgery
  • andexanet alfa
  • Phoenix, Arizona
  • +55 more
Jun 30, 2022

Gaucher Disease, Type 1 Trial in Worldwide (velaglucerase alfa, imiglucerase)

Completed
Has Results
  • Gaucher Disease, Type 1
  • velaglucerase alfa
  • imiglucerase
  • Durham, North Carolina
  • +10 more
May 14, 2021

Hemophilia A or B With Inhibitor Trial in Iran, Islamic Republic of, Turkey (Biosimilar eptacog alfa, activated (AryoSeven),

Completed
  • Hemophilia A or B With Inhibitor
  • Biosimilar eptacog alfa, activated (AryoSeven)
  • Eptacog alfa, activated (Novoseven)
  • Shiraz, Iran, Islamic Republic of
  • +7 more
Feb 3, 2021

Gaucher Disease Trial in Jerusalem, Bucharest, Belgrade (GA-GCB)

Completed
Has Results
  • Gaucher Disease
  • Jerusalem, Israel
  • +2 more
May 30, 2021

Hemophilia A With Inhibitor, Hemophilia B With Inhibitor Trial in Worldwide (MarzAA)

Terminated
  • Hemophilia A With Inhibitor
  • Hemophilia B With Inhibitor
  • MarzAA
  • Phoenix, Arizona
  • +42 more
Dec 2, 2021

Gaucher Disease Trial in Worldwide (GA-GCB (velaglucerase alfa))

Completed
Has Results
  • Gaucher Disease
  • GA-GCB (velaglucerase alfa)
  • Los Angeles, California
  • +14 more
May 26, 2021

Urgent Surgery Trial (Andexanet alfa, Usual Care)

Not yet recruiting
  • Urgent Surgery
  • Andexanet alfa
  • Usual Care
  • (no location specified)
Jun 21, 2023

NovoSeven® Treatment in Severe Postpartum Haemorrhage -Study at

Completed
  • Severe Postpartum Haemorrhage
  • Eptacog alfa (activated)
  • Standard of care
  • Bern, Switzerland
    Novo Nordisk Investigational Site
Jan 28, 2021

Observational Trial on Cytokine Adsorption in Sepsis

Recruiting
  • Sepsis
  • +2 more
    • Aachen, NRW, Germany
      University Hospital RWTH Aachen
    Nov 3, 2022

    Septic Shock Trial in Calgary (Therapeutic plasma exchange)

    Recruiting
    • Septic Shock
    • Therapeutic plasma exchange
    • Calgary, Alberta, Canada
    • +1 more
    Feb 15, 2022

    Andexanet Alfa: Non-interventional Study in Stroke Units in

    Recruiting
    • Intracranial Hemorrhages
      • Hannover, Germany
      • +1 more
      May 17, 2022

      Trauma, Traumatic Injury, Traumatic Brain Injury Trial in Worldwide (Epoetin Alfa 40000 UNT/ML, Sodium Chloride 0.9%)

      Recruiting
      • Trauma
      • +7 more
      • Epoetin Alfa 40000 UNT/ML
      • Sodium Chloride 0.9%
      • Camperdown, New South Wales, Australia
      • +34 more
      Nov 9, 2022

      Septic Shock Trial in Chicago (Dopamine, Norepinephrine)

      Completed
      Has Results
      • Septic Shock
      • Chicago, Illinois
        RUSH University Medical Center
      Dec 15, 2022

      Hypophosphatasia Trial in Worldwide (ALXN1850, asfotase alfa)

      Not yet recruiting
      • Hypophosphatasia
      • Hartford, Connecticut
      • +29 more
      Oct 6, 2023

      Fabry Disease Under Enzyme Replacement Therapy With

      Recruiting
      • Fabry Disease
      • Berlin, Germany
      • +7 more
      Oct 17, 2023

      Hypophosphatasia Trial in Würzburg (Ilofotase Alfa, 0.8 mg/kg, Ilofotase Alfa, 3.2 mg/kg)

      Recruiting
      • Hypophosphatasia
      • Ilofotase Alfa, 0.8 mg/kg
      • Ilofotase Alfa, 3.2 mg/kg
      • Würzburg, Germany
        Osteologie / Klinische Studieneinheit, Orthopädische Klinik - KL
      May 26, 2023

      Outcomes in Hospitalised Patients Treated With Ondexxya

      Not yet recruiting
      • Hemorrhage
      • Andexanet alfa
      • (no location specified)
      Jun 12, 2023

      Wound, Wound Infection, Wound Heal Trial in Xi'an (plasma activated saline, Routine nursing)

      Not yet recruiting
      • Wound
      • +2 more
      • plasma activated saline
      • Routine nursing
      • Xi'an, Shaanxi, China
        First Affiliated Hospital of Xian JiaotongUniversity
      Jul 5, 2023